Navigation Links
PharmAthene Reports Third Quarter 2009 Financial and Operational Results

for the Strategic National Stockpile, the award of government contracts to our competitors, unforeseen safety issues, challenges related to the development, scale-up, technology transfer, and/or process validation of manufacturing processes for our product candidates, unexpected determinations that these product candidates prove not to be effective and/or capable of being marketed as products, as well as risks detailed from time to time in PharmAthene's Forms 10-K and 10-Q under the caption "Risk Factors" and in its other reports filed with the U.S. Securities and Exchange Commission (the "SEC").

Copies of PharmAthene's public disclosure filings are available from its investor relations department and our website under the investor relations tab at

-Tables Follow-

                             PHARMATHENE, INC.

                                               September 30,   December 31,
                                                       2009           2008
                                                       ----           ----

     Current assets:
       Cash and cash equivalents                 $4,188,272    $19,752,404
       Restricted cash                                    -     12,000,000
       Short-term investments                     7,382,329      3,190,912
       Accounts receivable                        5,055,107      8,890,077
       Other receivables (including
        unbilled receivables)                    13,668,072      1,391,512
       Prepaid expenses and other
        current assets                            1,765,758        917,125
                                                  ---------        -------
     Total current assets                        32,059,538     46,142,030

     Long-term restricted cash                 
SOURCE PharmAthene, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Hearing Scheduled in the Delaware Court of Chancery for August 27, 2007 to Establish the Valid Approval and Consummation of the Merger Between PharmAthene, Inc. and Healthcare Acquisition Corp.
2. Proceedings to Affirm Merger Between PharmAthene and Healthcare Acquisition Corp Initiated in Delaware Chancery Court
3. PharmAthene Named as Contractor in $13.9 Million Award Notice Published by the Department of Health and Human Services
4. Delaware Court Denies Motion by SIGA Technologies Seeking to Dismiss PharmAthenes Legal Action in Breach of Contract Lawsuit Against SIGA
5. PharmAthene to Present at the BIO CEO & Investor Conference 2008
6. PharmAthene Enhances Executive Leadership Team and Appoints Joan Fusco, Ph.D. Senior Vice President of Operations
7. PharmAthene Completes Pharmacokinetic Studies of Protexia(R); Program on Target for IND Filing in 2008
8. PharmAthene to Present at the Cowen and Company 28th Annual Health Care Conference
9. PharmAthene Signs Definitive Agreement to Acquire Biodefense Vaccines Business From Avecia
10. PharmAthene to Delay Release of Full Year 2007 Financial Results
11. PharmAthene Year-End 2007 Earnings Conference Call and Webcast Scheduled for Monday, March 31, 2008
Post Your Comments:
(Date:6/3/2015)... Research and Markets ( ... "2015 Strategies in the US Immunoprotein ... offering. This new 236-page report ... market, including emerging tests, technologies, instrumentation, sales ... leading suppliers. During the next ...
(Date:6/3/2015)... BASEL, Switzerland , June 3, 2015 ... Research & Treatment of Cancer (EORTC), European Association of ... congress in Istanbul demonstrate that ... of methyltransferase (MGMT) status and in combination with radiotherapy ... EDO-S101 is a first in class fusion molecule that ...
(Date:6/3/2015)... CA (PRWEB) June 03, 2015 On April ... Senate Energy, Utilities and Communications Committee (11-0) and indicates the ... CAP) and renewable energy. , The Committee Chairman supports the ... increase the CAP by 8,000 GWh and would also like ... wait list. , This “Wait List” and timing are ...
(Date:6/3/2015)... June 03, 2015 Typical racks for ... preconfigured heights and depths often taking up unnecessary room ... Modular Ultra Low 5 Box Freezer Racks offer ... with existing freezer storage boxes and freezers. , ... for multiple experiments or multiple people because users can ...
Breaking Biology Technology:United States Strategies in the Immunoprotein Diagnostic Testing Market Report 2015 2Mundipharma EDO GmbH Data Confirm EDO-S101 is Effective in Preclinical Models of Human Glioblastoma 2Mundipharma EDO GmbH Data Confirm EDO-S101 is Effective in Preclinical Models of Human Glioblastoma 3Mundipharma EDO GmbH Data Confirm EDO-S101 is Effective in Preclinical Models of Human Glioblastoma 4Bmark Energy Announces the Sign-up Deadline for Companies Interested in California’s Direct Access Program is June 12th, 2015 at 5:00pm. 2Freezer Space Can Now Be Configured Your Way with New Modular Freezer Racks 2
... Health , Inc. (Nasdaq: GHDX ) today announced that ... November 8 at 4:30 p.m. Eastern Time to discuss its third ... release of the third quarter financial results after market close. ... access the live conference call on November 8 at 4:30 p.m. ...
... Verenium Corporation (Nasdaq: VRNM ), a ... solutions, today announced that it has renewed and extended ... global provider of heat transfer, separation and fluid handling ... Laval signed an agreement to jointly market enzymatic degumming ...
... the physiocrine therapeutics company, today announced a $23 ... Associates.  Domain joins existing venture investors Alta Partners, ... in the financing.  Proceeds will be used to ... advance physiocrine drug candidates into clinical trials.  Physiocrines ...
Cached Biology Technology:Genomic Health to Announce Third Quarter 2010 Financial Results and Host Conference Call on Monday, November 8, 2010 2Verenium and Alfa Laval Announce Extension of Purifine® PLC Enzyme Agreement 2Verenium and Alfa Laval Announce Extension of Purifine® PLC Enzyme Agreement 3Verenium and Alfa Laval Announce Extension of Purifine® PLC Enzyme Agreement 4aTyr Pharma Secures $23M Financing From Top Tier Venture Investor 2
(Date:5/27/2015)...   Codonics (, a global ... documentation solutions and Omnicell  (, a ... is pleased to announce their state of ... System® (SLS), an award-winning FDA class 2 ... Anesthesia Workstation, helps prevent medication errors, streamlines ...
(Date:5/25/2015)... May 25, 2015  Australia,s market for wearable technologies ... 2014 saw the advent of several trials and prototypes. ... 2015 is expected to ignite interest in wearables as ... Australia . This in turn will spur ... drive new partnerships amongst vendors and distributors. ...
(Date:5/22/2015)... May 22, 2015 According to ... Solution (2D, 3D, Thermal, Emotion, Forensic), by Software (Middleware, Databases), ... and Utilities, Consumer and Home) - Global Forecast to ... from $2.77 Billion in 2015 to $6.19 Billion by ... Browse 79 market data Tables and   43 Figures ...
Breaking Biology News(10 mins):Codonics and Omnicell Expand Partnership 2Codonics and Omnicell Expand Partnership 3Codonics and Omnicell Expand Partnership 4Australian wearables market to grow at CAGR of 78%; revenue of A$1 billion by 2018, says Frost & Sullivan 2Australian wearables market to grow at CAGR of 78%; revenue of A$1 billion by 2018, says Frost & Sullivan 3Australian wearables market to grow at CAGR of 78%; revenue of A$1 billion by 2018, says Frost & Sullivan 4Facial Recognition Market Worth $6.19 Billion by 2020 2Facial Recognition Market Worth $6.19 Billion by 2020 3
... documents dating back 3,500 years say they have found ... ancient Egypt and not with Hippocrates and the Greeks. ... Biomedical Egyptology at The University of Manchester discovered the ... before Hippocrates was born. , "Classical scholars have ...
... and Gail Williams and Stockholm University's Professor Robin Room examined ... and 2002. , Their results were published in the ... Review. , The men were categorised according to ... is a marker for lower socio-economic status (SES). ...
... Investigator, and Nancy Bae, Ph.D., Postdoctoral Research Associate ... offering insight into the way cells protect chromosome ... tomorrow's issue of Molecular Cell, their paper entitled ... Human Telomeric DNA Ends" employed a biochemical assay ...
Cached Biology News:Egyptians, not Greeks were true fathers of medicine 2Double the death rate from cirrhosis for 'blue collar' men 2Baumann Lab defines proteins that distinguish chromosome ends from DNA double-strand breaks 2
The S. cerevisiae Hansen strains are the parental yeast strains from which the deletions were derived....
Tissue culture grade....
The DNA DipStick Kit is ideal for estimating nucleic acid concentrations and approximate yields. Works with ss- and ds-DNA, RNA, and oligonucleotides at concentrations as low as 0.1 ng/l....
IHC detection kit for PCNA in cells and tissues...
Biology Products: